Pre-Open Movers 04/30: (OSTK) (TSLA) (FB) Higher; (CHK) (HGV) (TWTR) Lower (more...) Apr 30, 2020 09:27AM
After-Hours Stock Movers 04/29: (MRKR) (FB) (TSLA) Higher; (RIG) (CHK) (HIG) Lower (more...) Apr 29, 2020 05:53PM
Marker Therapeutics to Report Updated Results from Phase 1/2 Trial with MultiTAA Therapy in Patients with Pancreatic Adenocarcinoma Jun 20, 2019 07:00AM
Marker Therapeutics to Present at Two Upcoming Investor Conferences May 21, 2019 07:00AM
Marker Therapeutics Reports First Quarter 2019 Operating and Financial Results May 9, 2019 04:01PM


May 7, 2019 04:10PM Marker Therapeutics to Present at the Bank of America Merrill Lynch Health Care Conference
Mar 28, 2019 04:05PM Marker Therapeutics Provides Business and Clinical Update
Mar 18, 2019 07:00AM Marker Therapeutics to Host Business Update Conference Call and Webcast on Thursday, March 28th
Feb 25, 2019 07:00AM Marker Therapeutics Announces Clinical Update at the Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR 2019
Feb 21, 2019 06:00PM Marker Therapeutics Congratulates Helen E. Heslop, MD, DSc (Hon) on Receiving the ASBMT Lifetime Achievement Award
Feb 20, 2019 07:00AM Marker Therapeutics to Present at the CAR-TCR Summit Europe
Feb 15, 2019 04:30PM Marker Therapeutics Announces Change in Corporate Headquarters and Access to New Laboratory Facility
Feb 7, 2019 07:00AM Marker Therapeutics Appoints Mythili Koneru, M.D., Ph.D. as Senior Vice President, Clinical Development
Feb 6, 2019 07:00AM Marker Therapeutics to Present at the 2019 BIO CEO & Investor Conference
Jan 17, 2019 07:00AM Marker Therapeutics to Present at the Phacilitate Leaders World & World Stem Cell Summit 2019
Jan 15, 2019 04:30PM The Center for Cell and Gene Therapy at Baylor College of Medicine to Present at the Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR 2019
Jan 3, 2019 04:36PM Marker Therapeutics Provides Updates of its Lead Clinical Programs
Dec 6, 2018 07:00AM Marker Therapeutics to Present at the Tumor Targeted Lymphocytes Summit
Nov 27, 2018 04:32PM The Center for Cell and Gene Therapy at Baylor College of Medicine to Present at the 60th American Society of Hematology Annual Meeting
Nov 27, 2018 07:05AM Marker Therapeutics (MRKR) Appoints Anthony H. Kim as CFO
Nov 27, 2018 07:00AM Marker Therapeutics, Inc. Appoints Anthony H. Kim as Chief Financial Officer
Nov 8, 2018 06:30AM Marker Therapeutics to Present at Three Upcoming Healthcare Conferences
Oct 23, 2018 04:30PM Marker Therapeutics, Inc. Announces New Executive Appointments